02
Feb
2012
31
Jan
2012
Posted in I - Series E, Q - 4Q11, R - WEST, X - Cardiology, X - Device (Diagnostic), X - Metabolism, XX - CA
Aviir (Irvine, CA) a commercial-stage diagnostic company focused on pharmacogenomic and genetic tests for risk assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders, closed a $10M Series E financing. Participants include Merck Global Health Innovation, Bay City Capital, Aberdare Ventures and New Leaf Venture Partners.
31
Jan
2012
Posted in I - Series B, Q - 4Q11, R - WEST, X - ALS, X - Alzheimer's, X - Lysosomal Storage, X - Multiple Sclerosis, X - Neuro Degenerative, X - Parkinson's, XX - CA
Neuraltus Pharmaceuticals (Palo Alto, CA) a clinical-stage biopharmaceutical company focused on small molecule drugs for the neurodegenerative diseases such as ALS multiple sclerosis, Parkinson’s, Alzheimer’s, Fabry’s and Gaucher’s diseases, closed a $9.6M Series B financing. Participants include Latterell Venture Partners, VantagePoint Venture Partners and Adams Street Partners.
31
Jan
2012
Posted in I - Series E, Q - 4Q11, R - WEST, X - Autoimmune, X - Cardiology, X - Inflammation, XX - CA
Portola Pharmaceuticals (South San Francisco, CA) a clinical-stage small moelcule company focused on acute and chronic cardiovascular and autoimmune and inflammatory diseases, closed an $89M Series E financing. Participants included Temasek, Eastern Capital Limited, D.E. Shaw, Adage Capital Management, BBT Capital Management, Janus Capital Group and Pac-Link BioVentures.
31
Jan
2012
26
Jan
2012
26
Jan
2012
26
Jan
2012
Posted in I - Series B, Q - 3Q11, R - WEST, X - Dermatology, X - Inflammation, X - Opthalmology, XX - CA
SARcode (Brisbane, CA) a clinical-stage biopharmaceutical company focused on chronic T-cell mediated inflammation in ophthalmic and dermatologic disease, closed a $44M Series B financing. Participants include Sofinnova Ventures, Rho Ventures, Alta Partners and Clarus Venture Partners.
Thanx for your patience as we catch-up.
23
Jan
2012
Posted in I - Series D, Q - 3Q11, R - WEST, X - Device (Diabetes), X - Device (Diagnostic), XX - CA
Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a $12M Series D financing, bringing the total round to $76M. Participants include Accuitive Medical Ventures, Investor Growth Capital, Thomas McNerney, Venrock, Versant Ventures and U.S. Venture Partners.
Thanx for your patience as we catch-up.
19
Jan
2012
Posted in I - Series B, Q - 3Q11, R - WEST, X - Cardiology, X - Renal, XX - CA
Sorbent Therapeutics (Sunnyvale, CA) a clinical-stage biopharmaceutical company focused on development of adaptable non-absorbed polymeric drugs to for congestive heart failure, chronic kidney disease, end stage renal disease and hypertension, closed a $36M Series B financing. Participants include Novartis Venture Funds, Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem.
Thanx for your patience as we [...]
17
Jan
2012
Posted in I - Series B, Q - 3Q11, R - WEST, X - Device (Ophthalmology), XX - CA
Transcend Medical (Menlo Park, CA) a clinical-stage medical device company focused on the treatment of glaucoma, closed a $16 Series B, bringing the total round to $51M. Participants include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners.
Thanx for your [...]
12
Jan
2012
Posted in I - Series C, Q - 3Q11, R - WEST, X - Device (Hair Loss), X - Hair Loss, XX - CA
Restoration Robotics (Mountain View, CA) a clinical-stage medical device company focused on computer assisted image-guidance for hair follicle harvesting, closed a $41M Series C financing. Participants include Clarus Ventures, Sutter Hill Ventures, Alloy Ventures and Interwest.
Thanx for your patience as we catch-up.
12
Jan
2012